Ifp Advisors, Inc Xencor Inc Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Xencor Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 331 shares of XNCR stock, worth $7,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares
331
Previous 15,375 97.85%
Holding current value
$7,924
Previous $340,000 98.24%
% of portfolio
0.0%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
SELL
$18.21 - $24.5 $273,951 - $368,578
-15,044 Reduced 97.85%
331 $6,000
Q1 2024

Jul 30, 2024
SELL
$18.65 - $26.52 $2,778 - $3,951
-149 Reduced 0.96%
15,375 $340,000
Q4 2023

Jan 09, 2024
BUY
$16.53 - $21.42 $9,835 - $12,744
595 Added 3.99%
15,524 $329,000
Q3 2023

Oct 12, 2023
BUY
$20.08 - $25.39 $299,774 - $379,047
14,929 New
14,929 $300,000
Q1 2022

Aug 08, 2022
SELL
$26.68 - $41.63 $400 - $624
-15 Reduced 32.61%
31 $0
Q4 2021

Jan 12, 2022
BUY
$33.67 - $43.44 $1,548 - $1,998
46 New
46 $2,000
Q3 2021

Oct 06, 2021
SELL
$30.65 - $35.68 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021
BUY
$34.33 - $44.68 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021
BUY
$40.81 - $53.88 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021
SELL
$36.63 - $47.63 $293 - $381
-8 Closed
0 $0
Q3 2020

Oct 29, 2020
BUY
$30.09 - $43.02 $240 - $344
8 New
8 $0
Q2 2020

Aug 05, 2020
BUY
$27.76 - $33.42 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020
BUY
$20.69 - $37.79 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020
BUY
$32.75 - $41.43 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019
BUY
$33.73 - $46.27 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
SELL
$27.85 - $38.09 $696 - $952
-25 Closed
0 $0
Q3 2018

Oct 25, 2018
SELL
$35.69 - $47.65 $13,383 - $17,868
-375 Reduced 93.75%
25 $0
Q2 2016

Jun 03, 2019
BUY
N/A
400
400 $8,000

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.43B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email